Group items matching

in title, tags, annotations or url

Wegovy maker Novo Nordisk said on Tuesday (Aug 8) a large study had shown the highly effective obesity treatment also had a clear cardiovascular benefit, boosting the Danish company's hopes of moving beyond its image as a lifestyle drug. The increasingly popular Wegovy has transformed the weight-loss market since its U.S. launch in June 2021, capturing the attention of patients, investors and celebrities worldwide. Novo's news lifted shares in Europe's second-most valuable listed company after LVMH by more than 17 per cent to record highs. They have now surged almost 165 per cent over the past two years. The results of the late-stage trial may help persuade insurers in the U.S. and cost-conscious health authorities in Europe to cover the cost of Wegovy, which is $1,300 a month in the United States, for a wider range of patients. U.S. law classifies weight-loss treatments as lifestyle drugs and bars the Medicare health plan for older Americans from covering them and experts said the new data could lead the U.S. government to reassess that.

Novo Nordisk, the Danish drug manufacturer, has launched Wegovy, a weight-loss drug, in the UK market. This semaglutide injection will be available through specialist NHS weight management services for those who meet the National Institute for Care and Excellence (NICE) criteria or privately through registered healthcare professionals. Novo Nordisk allocated a portion of the available supply of Wegovy for NHS services, while confirming the existing shortage of semaglutide and projecting continued constraints in the foreseeable future. The drug can be obtained through the NHS and is additionally accessible for private purchase at pharmacies in the UK. The pricing for a one-month supply varies, ranging from £73.25 to £175.80, depending on the dosage. "We are committed to expanding treatment options for individuals with obesity and share the Government's goal of improving access to obesity care in areas of high unmet medical need," the company said in a statement. "We are closely monitoring Wegovy demand and collaborating with regulators and providers to ensure access to and continuity of treatment for people living with obesity."

Vasovagal syncope is a common and often benign condition characterized by a sudden loss of consciousness, typically triggered by certain stimuli or situations. While it can be alarming, understanding the underlying mechanisms, triggers, and management approaches can help individuals navigate this condition.

ভারতে কম হার্ট ট্রান্সপ্লান্ট সার্জারির খরচ এবং শূন্য অপেক্ষার সময়গুলি উল্লেখযোগ্যভাবে চিকিত্সা পর্যটকদের মধ্যে উল্লেখযোগ্যভাবে আঁকছে, বিশেষ করে রাষ্ট্রীয় চিকিৎসা ব্যবস্থার জন্য অর্থপ্রদান না করা দেশগুলির থেকে।

Les chirurgiens de transplantation cardiaque en Inde sont amicaux, comprennent la lutte et sont sensibles aux problèmes et aux préoccupations de la personne affectée ainsi qu'à la famille.

إن جراحي زراعة القلب في الهند ودودون ، ويتفهمون النضال ، وهم حساسون لقضايا ومخاوف الشخص المصاب وكذلك الأسرة.

ভারতে হার্ট ট্রান্সপ্লান্ট সার্জনরা বন্ধুত্বপূর্ণ, সংগ্রাম বোঝেন এবং আক্রান্ত ব্যক্তি এবং পরিবারের সমস্যা ও উদ্বেগের প্রতি সংবেদনশীল।

The UK government's community diagnostic centre programme, which was first launch in July 2021, is helping cut waiting lists, and speed up diagnoses and treatments for NHS patients. As of November 2023, a total of 6.1 million vital checks have been carried out at community diagnostic centres (CDCs) across England, according to a joint statement released by the Department of Health and Social Care (DHSC) and NHS England. Under the £2.3 billion programme, 141 CDCs have been opened across the country in a variety of settings including shopping centres, university campuses and football stadiums, offering patients a wide range of diagnostic tests closer to home. The government has set a target to open 160 CDCs by March 2025, with many expected to open ahead of schedule.

Patients can obtain the Manipal Hospital Delhi contact number as it represents a leading multi-specialty healthcare institution offering top-notch medical services.